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1. Introduction 
Vasculitis has historically been poorly defined and the histological and clinical 
manifestations are protean, further complicating the diagnostic process. The definitive 
diagnosis is made by evidence of histologic effacement of a vessel with associated 
transumural inflammatory infiltrate of that vessel. Vasculitis can be a primary process or 
secondary to disseminated intravascular coagulation, ulceration, arthropod assault, and/or 
suppurative infiltrates (for example pyoderma gangrenosum). Vasculitis must further be 
distinguished from vasculopathies, particularly livedoid vasculopathy and connective tissue 
diseases (namely scleroderma and systemic lupus erythematosus) in which the primary 
process is vascular fibrin thrombi of the upper dermal vessels. A necrotizing vasculitis 
resulting secondary to the thrombotic process can occur, blurring the lines between true 
vasculitis and vasculopathy. Very few vasculitic processes have pathognomonic histological 
findings. Often times the dermatopathologist and clinician must work in concert and 
combine clinical, histological, and laboratory data to determine what the primary process is. 
As previously stated, histological evidence of inflammatory infiltrate within the vessel wall 
must be seen in order to diagnose vasculitis. Associated findings include fibrinoid necrosis, 
endothelial swelling, and endothelial cell apoptosis (Carlson, et al., 2005). Other secondary 
changes including extravasation of red blood cells, necrosis, ulceration, and 
neovascularization suggest that there has been vascular damage (Carlson et al., 2005). 
Associated changes can also be seen in the sweat glands and include basal cell degeneration, 
necrosis, and basal cell hyperplasia (Akosa & Lampert, 1991). Changes in the adjacent tissue 
can aid the dermatopathologist in determining what the underlying etiology causing the 
vasculitis could be. Extravascular granulomas characterized by degenerating collagen 
bundles surrounded by eosinophils and flame figures (“red” granulomas) are seen in Churg 
Strauss Syndrome while extravascular granulomas characterized by degenerating collagen 
bundles surrounded by basophilic debris (“blue” granulomas) are seen in Wegener’s 
granulomatosis and rheumatoid vasculitis (Carlson, 2010). Dermal lamellar fibrosis can be 
seen in erythema elevatum diutinum and granulomas faciale (Carlson et al., 2005). Direct 
immunofluorescence adds another important diagnostic piece of information. Absence of 
immune complex deposition (pauci-immune vasculitis) is seen in Wegener’s 
granulomatosis, microscopic polyangiitis, and Churg Strauss syndrome (Carlson, 2010). 
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Peri-vascular deposition of IgG, IgM, and/or C3 is seen in cutaneous leukocytoclastic 
angiitis, urticarial vasculitis, and connective tissue disease vasculitis (Carlson et al., 2005). 
Vascular deposits of IgA are found in Henoch Schonlein purpura while deposition of IgM is 
seen in cryoglobulinemic vasculitis (Carlson, 2010). Basement membrane zone deposition of 
immunoglobulins can be seen in urticarial vasculitis and connective tissue disease vasculitis 
(Carlson et al., 2005). 
The most common classification system of vasculitides is based on the size of the affected 
vessel. While biopsy is required for definitive diagnosis, the size of the affected vessel 
correlates with the cutaneous lesions seen. Large vessel involvement manifests as limb 
claudication, absent pulses, aortic dilation, bruits, and/or asymmetric blood pressure (Chen & 
Carlson, 2008). Giant cell (temporal) arteritis and Takayasu’s arteritis are examples of this 
(Carlson, 2010). Vasculitis involving medium sized (muscular) vessels manifest as 
subcutaneous nodules, deep ulcers, livedo reticularis, palmar or digital scars, digital gangrene, 
mononeuritis, erythematous nodules, and aneurysms (Chen & Carlson, 2008). Examples of this 
include polyarteritis nodosa, Kawasaki disease, and nodular vasculitis (Carlson, 2010). Small 
vessel vasculitis can be further subdivided into two categories: immune complex mediated 
vasculitis arising in small post-capillary venules or non-immune complex mediated vasculitis 
arising in small muscular arteries and arterioles. Small vessel vasculitis appears as purpura, 
erythema, urticaria, vesiculobullous lesions, superficial ulcers, and splinter hemorrhages 
(Chen & Carlson, 2008). Examples of this include cutaneous leukocytoclastic vasculitis, 
Henoch Schonlein purpura, urticarial vasculitis, Churg Strauss vasculitis, Wegener’s 
granulomatosis, and microscopic polyangiitis (Carlson, 2010).  
Biopsy location, depth, and timing must be taken into consideration by the clinician to 
increase the diagnostic yield. Since small vessels reside in the upper dermis while medium 
sized, muscular vessels are found in the deep dermis and subcutis, a punch or excisional 
biopsy is required to ensure adequate sampling of all vessel sizes (Carlson et al., 2005). 
Biopsies performed within 48 hours after the onset of lesions can show a neutrophilic, 
eosinophilic, or lymphocytic infiltration, depending on the underlying process (Chen & 
Carlson, 2008). However, after 48 hours, lymphocytes replace the other inflammatory cells, 
regardless of the underlying etiology and will therefore be non-diagnostic (Chen & Carlson, 
2008). Fibrosis, luminal obliteration, and lamination of the vessel wall is seen in healed 
lesions of vasculitis (Chen et al., 2005). Biopsy from a patient with livedo racemosa must be 
taken from the center white areas rather then the peripheral red areas since this is where the 
vascular stenosis can be seen (Carlson, 2010). Biopsy of superficial ulcers should be taken 
from non-ulcerated skin or from the edge of the ulcer whereas biopsy of deep ulcers should 
be taken central to the ulcer and include subcutaneous tissue to increase the diagnostic yield 
of medium sized vessel vasculitis (Chen & Carlson, 2008). 
2. Small vessel vasculitis 
2.1 Immune complex mediated vasculitis in post capillary venules 
2.1.1 Cutaneous leukocytoclastic angiitis 
Cutaneous leukocytoclastic angiitis (CLA) is also known as cutaneous leukocytoclastic 
vasculitis, hypersensitivity vasculitis/angiitis, allergic vasculitis, and necrotizing vasculitis 
(Carlson & Chen, 2006). The Chapel Hill Consensus Conference (CHCC) defines CLA as an 
isolated cutaneous leukocytoclastic vasculitis in the absence of systemic vasculitis (Carlson 
et al., 2005). Patients are typically middle aged adults with a recent history of exercise in hot 
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weather (Chen & Carlson, 2008). Less than 10% of patients may present with renal or 
gastrointestinal involvement, however, this systemic vasculitis variant of CLA has yet to be 
formally recognized (Carlson, 2010). Etiology may be secondary to medications, viral upper 
respiratory infection, or collagen vascular diseases; however, in the majority of cases no 
etiology will be identified (Grunwald et al., 1997).  
The cutaneous manifestations include crops of palpable purpura over the lower extremities 
associated with pruritus, stinging, tenderness, or burning (Chen & Carlson, 2008). Rarely 
patients may present with erythema and hemorrhagic bullae on the lower extremities 
(Carlson, 2010). Areas of ecchymoses and hyperpigmenation are seen as the lesions resolve 
over a period of 3-4 weeks (Chen & Carlson, 2008).  
The general pathologic features of CLA on a skin biopsy include fibrin deposits, 
neutrophilic perivascular infiltration of small vessels, and nuclear debris (leukocytoclasia) 
(Carlson & Chen, 2006) (see Figures 1 and 2). Hemophagocytosis can also be seen (Draper & 
Morgan, 2007). The pathologic features of CLA change with temporal evolution. Early 
lesions are characterized by a neutrophil dominant vasculitis in the upper to mid dermis 
which then progresses to a mononuclear predominant vasculitis within 120 hours after the 
onset of the lesions (Zax et al., 1990) (see Figure 3). Epidermal involvement including vesicle 
formation and ulceration can also be identified (Grunwald et al., 1997). The healing lesions 
show regenerative endothelial cells, fibrin deposits within vessel walls, and a mild 
monocytic perivascular infiltrate (Grunwald et al., 1997) (see Figure 4). The other classic 
features of CLA including extravasation of erythrocytes, fibrinoid necrosis, and epidermal 
necrosis fade as the lesions age (Zax et al., 1990). Rarely a necrotizing venulitis can be seen 
extending through the mid and deep dermis (Carlson, 2010). 
 
 
 
Fig. 1. Cutaneous Leukocytoclastic Angiitis. Small vessel vasculitides demonstrate many 
common features including fibrinoid necrosis, marked inflammation, leukocytoclasia and 
red cell extravasation (H&E, 40x). 
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Fig. 2. Cutaneous Leukocytoclastic Angiitis. Neutrophilic perivascular infiltration of small 
vessels with accompanying leukocytoclasia consisting of karryorhectic nuclear debris (H&E, 
400x). 
 
 
Fig. 3. Cutaneous Leukocytoclastic Angiitis. Fibrinoid necrosis of the vessel walls is 
characteristic (H&E, 400x). 
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Fig. 4. Cutaneous Leukocytoclastic Angiitis. Intravascular fibrin thrombi are common and 
may be accompanied by epidermal infarction (H&E, 400x). 
Nuclear dust was previously considered to be pathoneumonic for CLA, however, several 
reports have shown it is also present in linear IgA bullous dermatosis, inflammatory type of 
epidermolysis bullosa acquisita, septic vasculitis, and dermatitis herpetiformis (LeBoit, 
2005). Further, not all nuclear dust is neutrophilic in origin. Lymphocytic inflammation can 
also result in nuclear dust in entities such as subcutaneous panniculitis like T-cell 
lymphoma, Kikuchi’s disease, and irritated lichenoid keratosis (LeBoit, 2005). 
Direct immunofluorescence is positive in 92% of cases and can be used during all stages of 
lesions (Grunwald et al., 1997). Detection of immunoreactants has the highest yield when 
taken from lesional rather than peri-lesional skin (Barnadas et al., 2004). Deposits of 
fibrinogen, C3 and IgM are most frequently present, but rarely IgG and C4 can also be seen 
(Grunwald et al., 1997). Deposition of IgA can also be seen in conjunction with IgM or IgG, 
distinguishing CLA from Henoch Schonlein Purpura in which IgA deposition is found in 
isolation (Sais & Vidaller, 2005). 
2.1.2 Urticarial vasculitis 
Urticarial vasculitis (UV) is a clinicopathologic entity characterized by urticarial lesions or 
faint purpura persisting longer than 24 hours which on histology show a leukocytoclastic 
vasculitis (Aboobaker & Greaves, 1986). Patients are typically female in their fourth to fifth 
decade of life (Chen & Carlson, 2008). Systemic symptoms such as fever, angioedema, 
arthralgias, and abdominal pain are usually present (Mehregan et al., 1992). Two clinical 
variants, hypocomplementemia UV (HUV) and normocomplementemia UV (NUV), exist. 
Patients with HUV are more likely to be female and present with more severe disease along 
with arthralgia, glomerulonephritis, uveitis, recurrent abdominal pain, and/or obstructive 
lung disease (Chen & Carlson, 2008). The cause of UV is mostly unknown;, however, it can 
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be a manifestation of connective tissue diseases such as systemic lupus erythematosus or 
Sjögren’s syndrome or be associated with viral infections, serum sickness, drug reactions, 
and exercise (Carlson & Chen, 2006).  
Cutaneous findings which help to distinguish UV from chronic urticaria include burning, 
painful, or pruritic hive-like plaques persisting longer than 24 hours but which fade within 
72 hours leaving residual areas of hypopigmentation (Carlson, 2010). Lesions tend to favor 
the trunk and proximal extremities (Fiorentino, 2003). 
The minimal criteria required for diagnosis of UV are leukocytoclasia or fibrin deposits with 
or without extravasated red blood cells, features which can be subtle and overlap with the 
histologic findings seen in cutaneous leukocytoclastic angiitis (Black, 1999). There is a wide 
spectrum of histologic findings in UV, ranging from sparse neutrophilic infiltrate of small 
vessels to more severe lesions with a dense neutrophilic vasculitis, leukocytoclasia, 
extravasated red blood cells, endothelial cell swelling and fibrin deposits (Jones et al., 1983). 
The superficial and mid-dermal vessels are most commonly affected, however, vascular 
destruction can extend into the deep dermal and pannicular vessels (Davis et al., 1998; 
Mehregan et al., 1992). Neutrophilic vasculitis is more common in HUV whereas 
eosinophilic vasculitis predominates in NUV (see Figure 5) (Davis et al., 1998). 
 
 
Fig. 5. Urticarial Vasculitis. A prominent eosinophilic infiltrate is present (H&E, 400x) 
Direct immunofluorescence reveals peri-vascular deposits of C3 and immunoglobulins, 
mostly IgM, however, DIF is more frequently positive in HUV as opposed to NUV (87% 
versus 29%) (Mehregan et al., 1992). Likewise, basement membrane deposition of 
immunoglobulins and/or C3 is seen on DIF, but more commonly in HUV than NUV (70% 
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versus 18%) (Mehregan et al., 1992). 70% of patients with basement membrane deposition of 
immunoreactants will also have glomerulonephritis (Chen & Carlson, 2008).  
2.1.3 Henoch schonlein purpura 
Henoch Schonlein Purpura (HSP) represents approximately 10% of all cutaneous vasculitis 
cases and is the most common vasculitis in children, comprising about 90% of all cases 
(Carlson, 2010). HSP typically occurs in children aged four to eight years old with a history 
of upper respiratory tract infection one to two weeks prior to onset of symptoms (Fiorentino, 
2003). The initial diagnosis of HSP required palpable purpura, gastrointestinal involvement, 
arthritis, and nephritis, however, it is now recognized that not all patients present with this 
tetrad of symptoms (Fiorentino, 2003). The only diagnostic criterion for HSP according to 
the Chapel Hill Consensus Conference (CHCC) guidelines is demonstration of IgA deposits 
affecting small vessels (Carlson et al., 2005). The CHCC definition is not specific for HSP, 
however, since IgA vascular deposits are also seen in erythema nodosum, venous stasis, 
cryoglobulinemia, coagulopathic vasculopathies, and livedoid vasculitis (Carlson & Chen, 
2006). The diagnosis of HSP according to the American College of Rheumatology (ACR) 
requires two of the following: palpable purpura, age less than 20 years, abdominal pain, 
and/or neutrophilic vasculitis (Carlson et al., 2005). One could confuse HSP with mixed 
cryoglobulinemia, Wegener’s granulomatosis, collagen vascular disease, 
hypocomplementemic vasculitis, and microscopic polyarteritis nodosa if only the more 
clinical ACR criteria are used for diagnosis, which does not require the demonstration of 
IgA deposits on direct immunofluorescence (DIF) (Magro & Crowson, 1999). Therefore, 
features more sensitive and specific for HSP include IgA vascular deposits and two or more 
of the following clinical features: age less than or equal to 20 years, abdominal pain or 
hematochezia, preceding upper respiratory tract infection, and/or hematuria or renal 
biopsy with mesangioproliferative glomerulonephritis with or without IgA deposits 
(Carlson, 2010). 
Long term follow up of these patients is paramount as 20% of children who present with 
renal involvement or who have an abnormal urinalysis at the time of diagnosis will progress 
to chronic renal failure within 20 years (Chen & Carlson, 2008). The presence of nephrotic 
syndrome, hypertension, or renal failure at the outset are poor prognostic factors in children 
(Carlson & Chen, 2006). Adults who present with fever, rash above the waist, and an 
elevated erythrocyte sedimentation rate are more likely to have renal involvement (Chen & 
Carlson, 2008). 
Cutaneous manifestations of HSP include symmetric macular erythema of the buttocks and 
lower extremities which progresses to palpable purpura that usually resolves within 10 to 14 
days (Fiorentino, 2003). 
The prototypic pathology of HSP shows a small vessel neutrophilic vasculitis 
indistinguishable from that seen in CLA (see Figure 6) (Carlson & Chen, 2006). At least three 
of the following features have been suggested as being specific for HSP: superficial plaques 
rather than palpable purpura, skin necrosis, retiform margins of lesions, or a livedoid 
pattern of hemorrhage (Piette & Stone, 1989). While the vasculitis is usually limited to the 
superficial and mid-dermal vessels, pandermal involvement can be seen (Magro & 
Crowson, 1999). A severe reaction which recapitulates a Sweet’s like vascular reaction, 
neutrophilic interface dermatitis, dermatitis herpetiformis like abscesses, and adnexal 
infiltration by neutrophils can also be seen (Magro & Crowson, 1999). 
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Fig. 6. Henoch Schonlein Purpura. Lesions of HSP are notable for marked red cell 
extravasation (H&E, 200x). 
DIF reveals vascular deposits of IgA, predominately the IgA1 subclass (Egan et al., 1998). 
The sensitivity of DIF increases dramatically when performed on biopsies of lesions less 
than 48 hours in duration as compared to lesions of longer duration (85% versus 27%) 
(Murali et al., 2002). 
Acute infantile hemorrhagic edema (AIHE) (also known as Finkelstein’s Disease) is 
considered by some to be a variant of HSP characterized by fever, annular or targetoid skin 
lesions, and edema, (Carlson & Chen, 2006). Other authors consider AIHE a distinct entity 
from HSP owing to the fact that patients with AIHE are younger and have shorter disease 
courses than those patients with HSP (Karremann et al., 2009). Additionally, complications 
common to HSP, such as intestinal bleeding and renal involvement, are rare in AIHE 
(Karremann et al., 2009). Sudden onset of symptoms is seen after an upper respiratory 
infection, drug ingestion, or vaccination (Millard et al., 1999). The same small vessel 
neutrophilic vasculitis seen in HSP is also seen in AIHE, however, deposition of IgA is not a 
feature in AIHE (Legrain et al., 1991). Patients typically follow a benign clinical course with 
spontaneous resolution in 12-20 days (Millard et al., 1999). 
2.1.4 Cryoglobulinemic vasculitis 
Cryoglobulins are immunoglobulins which will precipitate when serum is cooled to 
temperatures less than 37o C (Cohen et al., 1991). Cryoglobulinemia is divided into three 
types: Type I is composed of monoclonal immunoglobulins, type II has mixed monoclonal 
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and polyclonal immunoglobulins (monoclonal IgM and polyclonal IgG), and type III has 
only polyclonal immunoglobulins (polyclonal IgM and IgG) (Sansonno & Dammacco, 2005). 
Type I produces small vessel hyaline thrombi, not a true vasculitis, while types II and III 
result in cryoglobulinemic vasculitis (CV) (Carlson & Chen, 2006). Mixed 
cryoglobulinemia (types II and II) is associated with connective tissue diseases, 
lymphoproliferative disorders (although these are more frequently seen in association 
with type I), and infectious diseases (Cohen et al., 1991). Mixed cryoglobulinemia is 
frequently a manifestation of hepatitis C infection, although these patients less frequently 
present with vasculitis (Kapur et al., 2002).  
The clinical triad of CV (mixed cryoglobulinemia with vasculitis) includes purpura induced 
by exposure to cold or prolonged standing, arthralgia, and weakness (Chen & Carlson, 
2008). Non-pruritic, intermittent purpura invariably involving the lower extremities with 
facial and trunk sparring is always seen, however, petechiae, livedo reticularis, skin 
necrosis, ulcerations, and urticaria can rarely be present (Fiorentino, 2003). Other rare 
cutaneous presentations include polyarteritis nodosa like lesions, splinter hemorrhages, and 
palmar erythema (Chen & Carlson, 2008). Systemic manifestations include renal disease 
(presenting as hematuria, edema, or hypertension), liver disease (presenting from elevated 
liver enzymes and hepatomegaly to frank cirrhosis), gastrointestinal involvement 
(presenting as abdominal pain or gastrointestinal bleeding), lymphadenopathy, 
polyneuropathy, and pericarditis (Gorevic et al., 1980). 
Skin biopsy of CV will demonstrate a neutrophilic vasculitis equally affecting small 
vessels in the papillary dermis and subcutaneous tissue (Cohen et al., 1991). Other 
histologic findings include endothelial swelling, extravasation of red blood cells, hyaline 
thrombi, and fibrinoid necrosis (Cohen et al., 1991; Gorevic et al., 1980). Rarely a 
lymphocytic small vessel vasculitis can be seen (Cohen et al., 1991). Direct 
immunofluorescence frequently reveals the presence of immunoreactants in vessel walls 
(typically IgG, IgM and/or C3) (Cohen et al., 1991; Gorevic et al., 1980). Deposition of 
immunoreactants along the basement membrane zone is not commonly seen (Gorevic et 
al., 1980). Hepatitis C proteins can be detected within vessel walls, even in the absence of 
vasculitis, and also within keratinocytes in patients with Hepatitis C virus and concurrent 
acute vasculitis (Sansonno & Dammacco, 2005). 
2.1.5 Drug induced vasculitis 
Approximately 20% of all cutaneous vasculitis eruptions result from an adverse drug 
reaction (Carlson, 2010). The interval between ingestion of the drug and onset of the 
vasculitis varies from hours to years and can commence with dosage increases or re-
challenge with the agent (Carlson & Chen, 2006). The most common offenders in drug 
induced vasculitis include propylthiouracil, hydralazine, granulocyte-colony stimulating 
factor, cefaclor, minocycline, allopurinol, penicillamine, phenytoin, isotretinoin, and 
methotrexate (ten Holder et al., 2002). 
While specific cutaneous and systemic findings vary with the offending drug (see Table 1), 
patients who present with limited cutaneous vasculitis in the absence of systemic 
involvement usually present with a maculopapular or vesicular rash over the extremities 
while patients with systemic vasculitis typically present with a maculopapular, vesicular, or 
purpuric rash which is not limited to the extremities (Mullick et al., 1979).  
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 Systemic Organs Involved Cutaneous Findings Duration of 
Therapy before 
Onset of 
Symptoms 
Propylthiouracil Renal (focal segmental 
glomerulosclerosis, mesangial 
proliferation), Pulmonary 
(hemoptysis, wheezing, 
congestion, cough, dyspnea), 
Musculoskeletal (myositis, 
cramping, elevated creatine 
kinase), Ear (decreased hearing, 
bilateral deafness, tinnitus) 
Purpuric lesions progressing 
to necrotic ulcers 
3 days-7 years 
Hydralazine Renal (pauci-immune 
glomerulonephritis), Pulmonary, 
Musculoskeletal (arthralgias, 
myalgias) 
Palpable purpura, 
maculopapular eruptions on 
the lower extremities and 
hemorrhagic blisters on the 
legs, arms, trunk, nasal 
septum, and uvula 
6 months-13 years 
Granulocyte 
Colony Stimulating 
Factor 
Systemic symptoms less 
common; Renal (vasculitis), 
Musculoskeletal (arthralgias) 
Subcutaneous nodules, 
purpura, hemorrhagic bullae, 
erythematous macules 
Days to Weeks 
Allopurinol Always presents with systemic 
symptoms; Renal 
(glomerulonephritis), Hepatic 
(elevated liver enzymes, 
granulomatous infiltration), 
Musculoskeletal (myalgias), 
Other (lymphadenopathy, 
seizures)
Macular rash more 
prominent on the back and 
abdomen, non-follicular 
macular exanthem on trunk 
and proximal extremities, 
erythema multiforme 
2 hours-9 years 
Cefaclor Renal and Musculoskeletal Serum sickness like reaction 
limited to the face and 
extremities 
1-2 weeks 
Minocycline Renal (elevated creatinine), 
Hepatic (elevated liver enzymes), 
Ocular (conjunctivitis, swelling of 
the eye), Musculoskeletal 
(arthralgias, polyarthritis) 
Urticarial eruption, 
erythema nodosum, non-
palpable purpura, livedo 
reticularis, erythematous 
macular eruptions 
9 days-9 months 
Penicillamine Renal (glomerulonephritis), 
Pulmonary (coughing, 
hemoptysis, lung infiltrates) 
Cutaneous ulcers on hands 
and ears, purpuric rash 
2 months-18 years 
Phenytoin High mortality rate; vasculitis 
involving the kidney, liver, 
spleen, and lung 
Pruritic maculopapular rash 1 week-17 years 
Isotretinoin Renal (glomerulonephritis), 
Pulmonary (Wegener’s 
granulomatosis), Musculoskeletal 
(myalgias, arthralgias) 
Pruritic papules 6-16 weeks 
Methotrexate Fever Erythematous palpable 
purpura 
1-5 days 
Adapted from ten Holder et al., 2002 
Table 1. Drugs Most Frequently Associated with Vasculitis 
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Numerous cases report positive ANCA following ingestion of certain drugs. The drugs most 
commonly associated with ANCA positive vasculitis are propylthiouracil and hydralazine. 
Methimazole, phenytoin, thiazide, minocycline, allopurinol, penicillamine, sulfasalazine, 
cephotaxime, and retinoids have also been implicated (Cuellar, 2002). Cutaneous findings in 
patients with drug induced ANCA associated vasculitis include acral purpuric plaques and 
nodules, most commonly found on the extremities, face, breast, and ears (Fiorentino, 2003). 
Systemic involvement is more common in the ANCA associated drug induced vasculitides 
(Chen & Carlson, 2008). 
 Other drugs can cause a vasculitis which clinically and histologically resembles urticarial 
vasculitis (appetite suppressants, methotrexate, procainamide, fluoxetine), Churg Strauss 
syndrome (leukotriene inhibitors, macrolides), Henoch-Schonlein purpura 
(propylthiouracil, levodopa, carbidopa), and Wegener’s granulomatosis (propylthiouracil) 
(Cuellar, 2002). 
Skin biopsy usually reveals a leukocytoclastic vasculitis (LCV) similar to that seen in other 
small vessel vasculitis syndromes characterized by vascular and interstitial neutrophilic 
infiltration, leukocytoclasis, endothelial cell swelling, fibrinoid necrosis, and extravasation 
of red blood cells (Bahrami et al., 2006). Determining a drug induced versus non-drug 
induced etiology is a diagnostic dilemma for clinicians and pathologists. Tissue eosinophilia 
can be present in drug induced LCV, however, its existence does not exclude other non-
drug induced etiologies such as arthropod assault, which will also show prominent 
interstitial eosinophils (Bahrami et al., 2006). One study suggested the presence of vascular 
fibrin deposition should exclude a drug related LCV, however, later studies have failed to 
replicate this findings (Bahrami et al., 2006; Mullick et al., 1979). Intravascular fibrin thrombi 
and epidermal changes including vesicle formation can occasionally be seen (Bahrami et al., 
2006). 
Recent attention has been given to vasculitis secondary to cocaine adulterated with 
levamisole. Patients present clinically with retiform purpura and skin biopsy shows a 
leukocytoclastic vasculitis with thrombosis (Walsh et al., 2010). Mural fibrin, extravasated 
red blood cells, nuclear dust, and luminal thrombosis can also be seen (see Figure 7) (Waller 
et al., 2010). A diagnostic pit fall for clinicians and dermatopathologists is “cocaine-induced 
pseudovasculitis” in which the clinical and serologic findings are suggestive of vasculitis, 
but the histopathologic findings of vasculitis are absent (Friedman & Wolfsthal, 2005). These 
patients can also present with retiform purpura and skin biopsy shows fibrin thrombi 
occluding small superficial and deep dermal vessels without evidence of vasculitis (Waller 
et al., 2010). 
Recent attention has been given to vasculitis secondary to cocaine adulterated with 
levamisole. Patients present clinically with retiform purpura and skin biopsy shows a 
leukocytoclastic vasculitis with thrombosis (Walsh et al., 2010). Mural fibrin, extravasated 
red blood cells, nuclear dust, and luminal thrombosis can also be seen (see Figure 7) (Waller 
et al., 2010). A diagnostic pit fall for clinicians and dermatopathologists is “cocaine-induced 
pseudovasculitis” in which the clinical and serologic findings are suggestive of vasculitis, 
but the histopathologic findings of vasculitis are absent (Friedman & Wolfsthal, 2005). These 
patients can also present with retiform purpura and skin biopsy shows fibrin thrombi 
occluding small superficial and deep dermal vessels without evidence of vasculitis (Waller 
et al., 2010). 
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Fig. 7. Levamisole-Induced Vasculitis. Complete effacement of the vessel wall with 
extensive fibrin thrombosis and neutrophilic infiltrates reminiscent of an infectious etiology 
(H&E, 200x). 
2.1.6 Connective tissue disease associated vasculitis 
Connective tissue disease (CTD) vasculitis is an uncommon complication most frequently 
seen in patients with systemic erythematosus (SLE), rheumatoid arthritis (RA), and 
Sjögren’s syndrome (SS) but can also rarely be seen in dermatomyositis, scleroderma, and 
polychondritis (Carlson & Chen, 2006). The usual presentation is arterial and capillary 
involvement represented clinically by purpura, vesiculobullous lesions, urticaria, and 
splinter hemorrhages (Carlson, 2010). Ulcers, subcutaneous nodules, gangrene, livedo 
racemosa, and pyoderma gangrenosum can also be seen and represent arterial involvement 
(Carlson, 2010). 
Skin biopsy typically reveals a vasculitis of small vessels, although medium sized vessel 
involvement can occasionally be seen (see Figure 8) (Carlson, 2010). The findings of both 
small and medium sized vessel vasculitis in the same biopsy are characteristic of CTD 
vasculitis (Chen & Carlson, 2008). Patients with CTD vasculitis can show p-ANCA or, more 
rarely, c-ANCA on indirect immunofluorescence (Carlson & Chen, 2006). Serology for anti-
proteinase 3 and anti-myeloperoxidase is typically negative in these patients, ruling out 
Wegener’s granulomatosis and Churg Strauss syndrome, respectively (Merkel et al., 1997). 
While the histologic features of CTD vasculitis are similar despite the etiology, certain 
extravascular findings may help aid in distinguishing which specific CTD is present. 
Interface dermatitis with increased dermal mucin is seen in SLE and dermatomyositis; 
dermal sclerosis is seen in scleroderma; granulomatous dermatitis is seen in RA and SLE; 
and interstitial neutrophilia is seen in SLE and SS (Chen & Carlson, 2008). Chronic 
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lymphocytic vasculitis is the suspected etiology for endarteritis obliterans, a vasculopathy 
characterized by progressive blood vessel occlusion with subsequent internal organ 
ischemia seen in patients with CTD vasculitis (Carlson & Chen, 2006). 
2.1.7 Rheumatoid vasculitis 
Rheumatoid vasculitis (RV) is an uncommon complication of rheumatoid arthritis (RA) with 
significant mortality (Chen et al., 2002). RV is associated with high rheumatoid factor titer, 
joint erosions, extra-articular symptoms, rheumatoid nodules, male gender, increasing 
number of treatment with disease modifying agents, and prior treatment with D-
penicillamine or azathioprine (Sayah & English, 2005). Onset is typically 10-14 years after 
the onset of RA (Sayah & English, 2005). Diagnosis of RV requires RA plus one or more of 
the following: mononeuritis multiplex, acute peripheral neuropathy, peripheral gangrene, 
acute necrotizing vasculitis seen on biopsy plus systemic symptoms, or deep cutaneous 
ulcers or extra-articular disease if associated with infarcts or vasculitis (Sayah & English, 
2005). Cutaneous findings are the most common extra-articular manifestation in RV and can 
be seen in 80-89% of all patients and are frequently the presenting symptom (Chen et al., 
2002). Patients with cutaneous RV generally have a good prognosis while those with RV 
involving nerves or bowel typically have a fatal outcome (Carlson & Chen, 2006).  
 
 
Fig. 8. Lymphocytic Vasculitis. Connective tissue disease may present with a predominately 
lymphocytic infiltrate (H&E, 100x). 
Palpable purpura on the lower extremities is the most common cutaneous presentation 
(Genta et al., 2006). Other manifestations include ulcers, maculopapular erythema, 
hemorrhagic blisters, erythema elevatum diutinum, livedo reticularis, subcutaneous 
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nodules, and atrophie blanche (Chen et al., 2002). Ulcers tend to be found on the dorsum of 
the foot or upper calf, locations which are different from ulcerations due to atherosclerosis 
and diabetes, a finding which may help clinically distinguish these entities (Genta et al., 
2006). Small, brown, painless infarcts of the nail fold or edge, also known as Bywaters 
lesions, are characteristic of RV (Sayah & English, 2005).  
Histologic diagnosis of RV is complicated by the fact that vessels ranging from 
subcutaneous muscular arteries to venules can be involved and vessels in all stages of acute 
and healing vasculitis can be identified in the same specimen (Chen et al., 2002). Three 
histologic patterns of vasculitis may be seen. A necrotizing leukocytoclastic vasculitis of 
dermal venules is seen in patients with palpable purpura, hemorrhagic bullae, 
maculopapular erythema, and erythema elevatum diutinum (Chen et al., 2002). An acute or 
healing arteritis of the dermal-subcutaneous vessels similar to that seen in polyarteritis 
nodosa is seen in patients with subcutaneous nodules, livedo reticularis, and ulcers (Carlson 
& Chen, 2006). The last pattern is a mixed venulitis and arteritis and is seen in patients with 
subcutaneous nodules, atrophie blanche, and palpable purpura (Chen et al., 2002). Other 
histologic patterns that can be seen include folliculocentric neutrophilic vasculitis, pustular 
vasculitis with epidermal microabscess formation resembling dermatitis herpetiformis, and 
granulomatous vasculitis composed namely of lymphocytes and histiocytes (Magro & 
Crowson, 2003). Small vessel occlusive arteritis is seen in Bywaters lesions (Sayah & English, 
2005). Vascular deposition of immunoglobulin, typically IgM, can frequently be seen on 
direct immunofluorescence and is associated with the presence of extra-articular 
manifestations (Rapoport et al., 1980). 
2.1.8 Lupus vasculitis 
Lupus vasculitis (LV) can be seen in 19-36% of patients with systemic lupus erythematosus 
(SLE) and 7-12% of patients with subacute cutaneous lupus erythematous (SCLE) (Carlson 
& Chen, 2006). Patients with LV are more frequently younger, male patients when 
compared to SLE patients without vasculitis (Carlson & Chen, 2006). Laboratory 
abnormalities include anemia, an elevated erythrocyte sedimentation rate and anti-La/SS-B 
antibodies, which are more common in patients with LV than those with non-vasculitis SLE 
(Chen & Carlson, 2008). Systemic LV, with or without cutaneous LV, is associated with a 
higher rate of mortality (Carlson & Chen, 2006).  
The most common cutaneous findings are small painful macules or depressed punctuate 
scars over the palmar surfaces and finger tips which represent palmar and digital infarcts 
(Carlson & Chen, 2006). Other manifestations include palpable purpura, urticaria, and 
livedo reticularis of the lower extremities (Fiorentino, 2003).  
Neutrophilic vasculitis of small vessels is the most frequent histological findings on skin 
biopsy (Drenkard et al., 1997). Neutrophilic or lymphocytic vasculitis involving medium 
sized muscular vessels can also be seen (Carlson & Chen, 2006). Biopsies of punctuate 
palmar lesions or areas of livedo reticularis show typical findings of livedoid vasculitis 
such as thickening and hyalinization of dermal and subcutaneous small and muscular 
vessels, inconspicuous lymphocytic perivascular infiltration, endothelial swelling, 
occlusion of the vessel lumen by fibrin, and endothelial necrosis can also be seen (Yasue, 
1986). Livedoid vasculitis is associated with an increased risk of developing SLE involving 
the central nervous system (Yasue, 1986). Concomitant findings of cutaneous lupus 
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erythematosus and LV can be seen within the same biopsy (Carlson & Chen, 2006). Direct 
immunofluorescence will reveal vascular deposition of IgG, IgM, or complement in 
approximately 55% of cases and co-existing basement membrane zone deposition of 
immunoglobulins (mostly IgM but rarely IgG) and complement in 60% of cases (Yasue, 
1986). 
2.1.9 Sjögren’s syndrome 
Sjögren’s syndrome (SS) is an autoimmune disease primarily affecting exocrine glands 
leading to dry mouth and dry eyes (Ramos-Casals et al., 2004). Patients with SS vasculitis 
are more likely to have systemic involvement of their disease such as arthritis, peripheral 
neuropathy, central nervous system vasculitis, Raynaud’s phenomenon, and renal disease 
(Carlson & Chen, 2006). Presence of antinuclear antibodies, anti-Ro/SS-A antibodies, 
rheumatoid factor, and cryoglobulins are frequent laboratory findings (Carlson & Chen, 
2006). 
The most common cutaneous findings are urticaria, palpable purpura, and ecchymoses 
(Fiorentino, 2003). Erythema multiforme, erythema perstans, and erythema nodosum can 
also be seen (Alexander & Provost, 1987).  
Two distinct histologic patterns are seen. A neutrophilic vasculitis with extravasation of red 
blood cells, fibrin deposition, and nuclear dust is seen in patients with antinuclear 
antibodies, high titers of anti-Ro/SS-A and anti-La/SS-B antibodies, 
hypergammaglobulinemia, hypocomplementemia, and positive rheumatoid factor 
(Alexander & Provost, 1987). A lymphocytic vasculitis with fibrinoid necrosis is associated 
with negative antinuclear antibodies, low titers of anti-RO/SS-A and anti-La/SS-B 
antibodies, normocomplementemia, and normal globulin levels (Alexander & Provost, 
1987). Necrotizing vasculitis of medium sized vessels can occasionally be seen (Ramos-
Casals et al., 2004). 
2.1.10 Erythema elevatum diutinum 
Erythema elevatum diutinum (EED) is a chronic relapsing and remitting cutaneous 
vasculitis occurring in middle aged patients (Wahl et al., 2005). While the etiology is largely 
unknown, there is an association between EED and connective tissue disease, infectious 
agents (hepatitis, syphilis, HIV, and Streptococcus), and hematological abnormalities 
(myelodysplasia, multiple myeloma, and lymphoma) (Wahl et al., 2005). ANCA can 
occasionally be detected in patients with EED (Carlson & Chen, 2006). Lesions are typically 
symmetric, tender, red or brown papules, plaques, or nodules on the extensor surfaces of 
the extremities (Yiannias et al., 1992).  
Skin biopsy of early lesions reveals a leukocytoclastic vasculitis of small vessels in which 
neutrophils are the predominant inflammatory cell (see Figure 9) (Yiannias et al., 1992). The 
dermis is relatively cellular with fibroblasts, histiocytes, and neutrophils predominating 
with relatively sparring of the epidermis and papillary dermis (Wahl et al., 2005). Older 
lesions show predominately fibrosis and granulation tissue with some lesions showing 
xanthomatization of the mid-dermis (Yiannias et al., 1992). Dense areas of laminated fibrosis 
contributes to the nodular appearance seen clinically (LeBoit & Cockerell, 1993). Direct 
immunofluorescence is generally non-diagnostic, but vascular deposition of IgG, IgM, 
complement (C3), and fibrinogen can be seen (Yiannias et al., 1992). 
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2.1.11 Granuloma faciale 
Granuloma faciale (GF) usually presents in middle aged adults as red-brown plaques, 
nodules, or papules which usually arise on the face (Ortonne et al., 2005). Clinically, these 
lesions can be mistaken for sarcoidosis, lymphoma, discoid lupus erythematosus, and basal 
cell carcinoma (Carlson & Chen, 2006). 
Skin biopsy shows a leukocytoclastic vasculitis within in the upper and reticular dermis 
and rarely involves the hypodermis (Marcoval et al., 2004). The dermis densely infiltrated 
by inflammatory cells, predominately eosinophils and plasma cells, distinguishing this 
entity from erythema elevatum diutinum, where neutrophils predominate (see Figure 10) 
(LeBoit, 2002). The cellular dermis is separated from the unremarkable epidermis by a 
grenz zone (see Figure 11) (Ortonne et al., 2005). Fibrinoid necrosis, extravasated red 
blood cells, and hemosiderin deposition can also be seen (Marcoval et al., 2004). 
Concentric perivascular fibrosis can be seen in older lesions (LeBoit, 2002). Perivascular 
and basement membrane deposition of immunoglobulins (mostly IgG but also IgA and 
IgM), complement (C3), and fibrinogen can be seen on direct immunofluorescence 
(Barnadas et al., 2005). 
 
 
 
 
 
 
 
 
Fig. 9. Erythema Elevatum Diutinum. Older lesions are characterized by dermal sclerosis 
and scarring (H&E, 100x). 
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Fig. 10. Granuloma Faciale. Numerous eosinophils are present in the mixed dermal infiltrate 
(H&E, 400x) 
 
 
 
Fig. 11. Granuloma Faciale. A dense inflammatory infiltrate fills the dermis underneath a 
prominent Grenz zone (H&E, 100x). 
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2.2 Non-immune complex mediated vasculitis in small muscular arteries and 
arterioles 
2.2.1 Churg strauss syndrome 
Churg Strauss Syndrome (CSS) is a clinically distinct entity characterized by asthma 
(usually adult onset), allergic symptoms (ex. allergic rhinitis), peripheral and tissue 
eosinophilia, and systemic vasculitis affecting small to medium sized vessels (Chen & 
Carlson, 2008). The classic presentation follows three phases, the prodromal phase which 
consists of atopic disease, namely asthma or allergic rhinitis followed by the second phase 
consisting of peripheral and tissue eosinophilia and finally the third phase which is 
heralded by a life threatening systemic vasculitis (Lanham et al., 1984). Cutaneous lesions 
accompanied by peripheral neuropathy are the most common clinical symptoms (Chen et 
al., 2007). Other clinical findings include pulmonary infiltrates, abdominal pain, intestinal 
obstruction leading to perforation (secondary to obstructive submucosal eosinophilic 
infiltrates), pericarditis, congestive heart failure, neuropathy, joint pain, and myalgia 
(Lanham et al., 1984). Renal involvement in the form of focal segmental glomerulonephritis 
is rarely seen (Lanham et al., 1984). The renal findings in CSS and Wegener’s granulomatosis 
are indistinguishable; however, renal involvement in CSS is extraordinarily rare and follows 
a benign course whereas renal disease is common in Wegener’s granulomatosis and 
frequently leads to renal failure (Lanham et al., 1984).  
Laboratory findings typically include eosinophilia and elevated IgE; approximately two 
thirds of patients will have a positive ANCA, usually p-ANCA (Frankel et al., 2002). Patients 
with a positive p-ANCA are more likely to have vasculitis and renal and central nervous 
system involvement (Choi et al., 2008). Vaccination, leukotriene inhibitors, and withdraw of 
corticosteroids have all been implicated as possible factors precipitating the onset of 
symptoms (Fiorentino, 2003). 
Three main types of cutaneous lesions are seen: erythematous maculopapules, 
hemorrhagic lesions (ranging from petechiae to ecchymosis) associated with necrosis and 
ulceration, and tender, deep seated nodules on the scalp and temple (Choi et al., 2008). 
Other cutaneous manifestations include livedo reticularis, wheals, vesicles, and bullae 
(Chen et al., 2007).  
Skin biopsy reveals three major histologic features: eosinophilic and neutrophilic vasculitis 
of small to medium sized vessels in the superficial and mid-dermal vessels ranging from a 
mild perivascular cuffing of inflammatory cells to a necrotizing arteritis which can 
recapitulate polyarteritis nodosa (PAN); interstitial dermal infiltration with eosinophils; or 
granulomas (see Figure 12) (Carlson & Chen, 2006; Lanham et al., 1984). All three histologic 
patterns may be seen in the same biopsy (Lanham et al., 1984). While the vasculitis typically 
involves small vessels, medium sized vasculitis can also occasionally be seen (Lanham et al., 
1984). Lesions in the healing stages will show fibrosis with calcified nodules and a sparse or 
complete absence of inflammatory cells (Carlson & Chen, 2006; Chen et al., 2007). This is in 
contrast to PAN where the acute stage is marked by neutrophils and the healing stage by 
lymphocytes and histiocytes (Chen et al., 2007). 
Two types of extravascular granulomas exist. The “blue” granulomas show palisading 
histiocytes surrounding basophilic degenerated collagen bundles (Chen et al., 2007). “Red” 
granulomas are also characterized by palisading histiocytes which surround a central zone 
of eosinophilic debris and collagen bundles (Carlson, 2010). While granulomatous arteritis 
may be found within internal organs of patients with CSS, the initial series report by Churg 
and Strauss only demonstrated perivascular or extravascular granulomas within skin 
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Fig. 12. Churg-Strauss Syndrome. Medium-sized vessel vasculitis with a prominent 
eosinophilic infiltrate (H&E. 100x). 
lesions (Churg & Strauss, 1951). Granulomatous arteritis is a relatively rare findings in CSS. 
Chen et al recently suggested five scenarios which may contribute to the infrequency of this 
finding: biopsy was not performed over areas of livedo reticularis; biopsy did not extend 
into the subcutis; serial sections on the specimen were not performed; biopsy was taken 
after the start of treatment; or biopsy was not taken during the granulomatous stage (Chen 
et al., 2007). Direct immunofluorescence is typically negative giving rise to the name “pauci-
immune” vasculitis (Carlson, 2010). 
2.2.2 Wegener’s granulomatosis 
The initial description of Wegener’s granulomatosis (WG) included three clinical findings: 
necrotizing granulomas with a predilection for the upper and lower airways, systemic small 
vessel vasculitis, and pauci-immune glomerulonephritis (Fiorentino, 2003). The most 
common initial presentation involves the upper and lower airways, with renal development 
occurring later (Frankel et al., 2002). Since all three clinical features are only concurrently 
present in 16% of patients, other criteria are used to establish the diagnosis (Carlson & Chen, 
2006). The Chapel Hill Consensus Conference (CHCC) defined WG as necrotizing vasculitis 
of the small to medium size vessels and granulomatous inflammation of the respiratory tract 
(Jennette et al., 1994). The documentation of granulomas does not necessarily require 
histology, but can rather be made using non-invasive techniques such as radiology (Jennette 
et al., 1994). The CHCC recognized, however, that the broad definition they used to classify 
WG left significant overlap between WG and microscopic polyangiitis (Jennette et al., 1994). 
The American College of Rheumatology (ACR) criteria for diagnosis requires two or more of 
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the following: nasal or oral inflammation, chest x-ray showing nodules, infiltrates, or 
cavities, microscopic hematuria, and/or granulomatous inflammation on biopsy (Carlson et 
al., 2005). The positive predictive value of the ACR criteria for diagnosing WG ranges from 
25-40% (Rae et al., 1998). Typical laboratory findings include a positive C-ANCA in 75-80% 
of patients (Fiorentino, 2003). WG is highly fatal, with a one year mortality rate of greater 
than 80% in untreated patients (Chen & Carlson, 2008). Relapse within 5 years occurs in 50% 
of patients (Carlson & Chen, 2006). 
A limited form of WG which typically involves younger patients is characterized by no or 
minimal renal dysfunction, limited pulmonary involvement, and no critical organ 
involvement (i.e., gastrointestinal, ocular, or central nervous system) exists (Carlson & Chen, 
2006). The cutaneous presentation is usually limited to purpura or ulcers (Carlson & Chen, 
2006). 
Cutaneous lesions are found in 50% of patients but may be the presenting symptoms in up 
to 10% of cases (Chen & Carlson, 2008). Cutaneous manifestations fall into three categories: 
palpable or non-palpable purpura which reflects a small vessel vasculitis; ulcers or digital 
infarcts secondary to small to medium sized vessel vasculitis; or polymorphic lesions 
including rheumatoid like nodules over the extensor surfaces, urticaria, vesiculobullous 
lesions, gingival hyperplasia, or ulcers like those seen in pyoderma gangrenosum, resulting 
from extravascular granulomas (Carlson, 2010). Other dermatological manifestations 
include petechiae, bullae, and erythema (Daoud et al., 1994). Mucosal ulcerations, 
xanthomas, and livedo reticularis can also be seen (Francès et al., 1994). A larger, 
suppurative ulceration involving the entire orbit and zygoma has been reported in a patient 
with limited WG (Bull et al., 1993). Hemorrhagic bullous plaques and erythematous 
pustules reminiscent of Sweet's syndrome have been described (Gürses et al., 2000). 
Four histological patterns can be seen on skin biopsies: (1) Leukocytoclastic vasculitis (LCV) 
characterized by necrotizing, neutrophilic vasculitis of small to medium sized dermal blood 
vessels; (2) Palisading granulomas with a central core of basophilic collagen surrounded by 
histiocytes and neutrophils reminiscent of granulomas seen in Churg-Strauss syndrome; (3) 
Granulomatous vasculitis with perivascular and periadnexal lymphohistiocytic 
granulomatous infiltrate and giant cells within the walls of muscular vessels of the subcutis; 
and (4) Perivascular and periadnexal infiltration of granulomas composed of large, atypical 
lymphocytes (see Figure 13) (Hu et al., 1977). Other non-specific histological findings 
include fibrin deposition within the lumen of and surrounding blood vessels, extravasation 
of red blood cells, endothelial cell swelling, and nuclear debris (Barksdale et al., 1995). 
Histological findings in patients with WG but without cutaneous vasculitis include foreign 
body giant cell reaction, fibrosis, hemorrhage, pseudoepitheliomatous hyperplasia, and 
interstitial eosinophilia (Carlson & Chen, 2006). Epidermal changes are rarely seen and 
include bulla formation and epidermal necrosis (Daoud et al., 1994). Biopsies of cutaneous 
lesions from patients with limited WG will often show granulomatous dermatitis but will 
seldom show vasculitis (Carlson & Chen, 2006).  
Patients presenting with necrotizing vasculitis or granulomas composed of lymphocytes 
have a higher mortality rate than those presenting with palisading granulomas or 
granulomatous vasculitis (Hu et al., 1977). The cutaneous pathology correlates with the 
presence of systemic disease, specifically with respect to articular and renal involvement 
(Francès et al., 1994). Patients presenting with LCV are more likely to have concurrent 
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musculoskeletal and renal involvement and a more rapidly progressive disease course when 
compared to patients without cutaneous manifestations and are more likely to, over time, 
develop renal, musculoskeletal, and ocular manifestations when compared to patients with 
granulomatous dermatitis (Barksdale et al., 1995).  
 
 
Fig. 13. Wegener's Granulomatosis. Granulomatous and necrotizing vasculitis can be seen in 
this section of pulmonary artery (H&E, 200x). 
While direct immunofluorescence typically fails to demonstrate immunoglobulin or 
complement deposition on renal biopsies, skin biopsies frequently show perivascular 
deposits of IgG, IgM, IgA, and C3 in subepidermal and dermal vessels (Brons et al., 2001). In 
patients who have had a relapse of WG, immunoglobulin deposits can be seen along the 
basement membrane and within the dermis (Brons et al., 2001). 
2.2.3 Microscopic polyangiitis (microscopic polyarteritis) 
Microscopic polyangiitis (MPA) is a systemic neutrophilic vasculitis of small vessels 
(Carlson, 2010). Men are slightly more affected then women and the average age of onset is 
50 years (Guillevin et al., 1999). The major systemic finding includes rapidly progressive 
focal segmental necrotizing glomerulonephritis; pulmonary hemorrhage, skin involvement, 
and antibodies to p-ANCA are also frequently present (Frankel et al., 2002). A prodromal 
phase consisting of weight loss, fatigue, fevers, arthralgias, and myalgias is often present 
months to years before the acute onset of the disease (Fiorentino, 2003). Drugs (specifically 
antibiotics), hepatitis B, streptococcal infection, and neoplasia have all been implicated as 
inciting factors in MPA (Savage et al., 1985). The overall mortality rate for MPA is 32%, 
similar to polyarteritis nodosa (PAN), Wegener’s granulomatosis (WG), and Churg-Strauss 
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syndrome (CSS), however, relapses are more frequent in MPA than seen in the other 
vasculitis syndromes (Guillevin et al., 1999). Since the histologic features of MPA are similar 
and in some instances indistinguishable from WG and CSS, the following criteria have been 
suggested for diagnosis: 1) no evidence of granulomatous inflammation (either by histology 
or radiology), 2) neutrophilic vasculitis of small vessels and/or glomerulonephritis without 
immune complex deposition, and 3) involvement of two or more organ systems as 
documented by biopsy or other laboratory or radiological markers (i.e., proteinuria, 
hematuria) (Chen & Carlson, 2008). 
Up to 15% of patients with MPA will present with skin disease and 65% or less will develop 
skin disease throughout the course of their illness (Carlson & Chen, 2006). The most 
common cutaneous presentation is palpable purpura and petechiae (Seishima et al., 2004). 
Other manifestations include splinter hemorrhages, nodules, palmar erythema, livedo, 
urticaria, hemorrhagic bullae, infarcts, facial edema, annular purpura, ulcers, and 
telangiectases (Carlson & Chen, 2006). One case of MPA reported in a patient with palpable 
purpura, myalgias, anorexia, and synovitis but no evidence of pulmonary or renal 
involvement suggests that a cutaneous limited variant of MPA may exist (Irvine et al., 1997). 
While a wide spectrum of pathologic changes can be seen, the classic histologic features of 
MPA on skin biopsy include a neutrophilic vasculitis of small vessels in the upper to mid-
dermis and subcutis (Carlson & Chen, 2006). Rarely medium sized vessels can be involved 
(Lhote et al., 1998). Other findings on the histologic continuum of MPA include lymphocytic 
perivascular infiltration in the upper dermis, mixed lymphocytic and neutrophilic 
perivascular infiltration in the mid to deep dermis, and mixed lymphocytic and histiocytic 
perivascular infiltration in the mid dermis (Seishima et al., 2004). Other non-specific findings 
of leukocytoclastic vasculitis similar to those seen in cutaneous leukocytoclastic angiitis 
(CLA) include fibrinoid necrosis and leukocytoclasis (Homas et al., 1992). The clinical 
appearance of livedo racemosa presents histologically as a vasculitis affecting deep dermal 
and subcutaneous vessels and a deep incisional biopsy is indicated in these patients to 
ensure that the subcutis is sampled (Nagai et al., 2009). Rarely patients can present with oral 
ulcerations which will also reveal a small vessel vasculitis on histologic examination (Savage 
et al., 1985). A unique histologic finding in MPA is the presence of active vasculitis, healed 
vessels, and unaffected vessels in the same tissue biopsy (Lhote et al., 1998).  
Small vessel vasculitis is diagnostic of MPA and excludes the diagnosis of PAN, even if 
medium sized vessels are involved (Lhote et al., 1998). Further, vascular nephropathy is the 
common renal finding in PAN whereas MPA is characterized by rapidly progressive focal 
segmental necrotizing glomerulonephritis (Lhote et al., 1998). WG is another small vessel 
vasculitis similar to MPA, however, granulomatous inflammation characteristic of WG is 
absent in MPA (Lhote et al., 1998). Absence of immunoglobulin deposition on direct 
immunofluorescence distinguishes MPA from CLA (Carlson & Chen, 2006). 
2.2.4 Septic vasculitis 
Approximately 22% of all cases of cutaneous vasculitis are associated with an infectious 
etiology (viruses, bacteria, fungi, protozoa, and helminthes) (Chen & Carlson, 2008). 
Organisms that have been implicated include Neisseria meningitides, Neisseria gonnorhoeae, 
Pseudomonas, Staphylococcus aureus, Hemophilus influenzae, Streptococcus, and Rickettsia 
(Carlson & Chen, 2006).  
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Cutaneous findings include hemorrhagic petechiae, pustular purpura, vesicles, bullae, 
erythematous macules, and nodules surrounded by pustules (Carlson & Chen, 2006). 
Patients with chronic gonococcemia and chronic meningococcemia typically present with 
petechiae surrounded by a rim of erythematous vesicles and pustules with a necrotic surface 
on the extremities, particularly acral surfaces (Chen & Carlson, 2008).  
Biopsy reveals a mixed small and medium sized vessel neutrophilic vasculitis of deep 
dermal and subcutaneous vessels (see Figure 14) (Chen & Carlson, 2008). Vessel occlusion 
with thrombi composed of platelets and red blood cells is also seen (Sotto et al., 1976). As 
compared to conventional small vessel neutrophilic vasculitis, septic vasculitis has scant 
perivascular fibrin and fibrin thrombi and little to no nuclear debris (Carlson, 2010). 
Arteriolar involvement, hemorrhage, and subepidermal and intraepidermal pustules help 
distinguish septic vasculitis from cutaneous leukocytoclastic angiitis (Shapiro et al., 1973). 
Epidermal changes include edema, intra-epidermal or subcorneal pustules, and epidermal 
necrosis (Shapiro et al., 1973). Gram stain is typically negative in septic vasculitis, however, 
gram negative rods can be seen within the cytoplasm of neutrophils, within endothelial 
cells, and admixed with extravasated red blood cells in acute meningococcemia (Sotto et al., 
1976). Gram negative diplococci can be isolated in gonococcemia if there is a high bacterial 
load and if lesions are biopsied early (Ackerman et al., 1965). Deposition of IgG, IgM, IgA, 
complement, and fibrinogen can be seen on direct immunofluorescence in acute 
meningococcemia (Sotto et al., 1976).  
 
 
 
Fig. 14. Septic Vasculitis. Note the distinct neutrophilia and abundant karyorrhectic debris 
and near complete destruction of the vessel wall (H&E, 200x). 
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2.2.5 Behçet’s disease 
Behçet’s disease (BD) is a chronic inflammatory disease characterized by oral and genital 
ulcers, arthralgias, gastrointestinal symptoms, and central nervous system involvement 
(Chen et al., 1997). Cutaneous manifestations include erythema nodosum like nodules, 
follicular lesions, or papulopustular lesions or rarely can include palpable purpura, 
hemorrhagic bullae, erythema multiforme like lesions, or pyoderma gangrenosum like 
lesions (Chen et al., 1997).  
While BD is typically classified as a neutrophilic dermatosis, recent evidence has 
suggested that it should rather be categorized as a cutaneous vasculitis (Chen et al., 1997). 
BD is unique in that it involves the entire spectrum of blood vessels, ranging from 
capillaries to the aorta (Carlson & Chen, 2006). Biopsy reveals a neutrophilic, and rarely a 
lymphocytic, vasculitis of medium sized vessels in the subcutis and venules throughout 
the dermis and subcutis (Chen et al., 1997). Biopsy of erythema nodosum like lesions 
show a subcutaneous thrombophlebitis with a lymphocytic vasculitis in the overlying 
dermis (Carlson & Chen, 2006). Fibrinoid necrosis, nuclear dust, panniculitis, venulitis in 
the dermis and subcutis, and necrotizing venulitis can also be seen (Chen et al., 1997). 
Direct immunofluorescence rarely shows deposition of IgA, IgM, and/or complement (C3 
or C1q) (Chen et al., 1997). 
3. Medium sized vessel vasculitis 
3.1 Polyarteritis nodosa 
Polyarteritis nodosa (PAN) is a relatively rare vasculitis of medium sized vessels which 
presents equally in men and women between the ages of 40 to 60 years (Carlson & Chen, 
2007). While the etiology in most cases of PAN is unknown, there is a strong association 
with hepatitis B virus (Frankel et al., 2002). Patients may present with a wide range of 
constitutional symptoms including fever, weight loss, arthralgias, muscle wasting, 
abdominal pain (usually as a result of bowel infarction and perforation), mononeuritis 
multiplex, hypertension, orchitis, and congestive heart failure (Colmegna & Maldonado-
Cocco, 2005). Renal manifestations in PAN typically include a primary vascular 
nephropathy presenting as multiple aneurysms in branches of the renal artery which 
leads to hypertension and rare pulmonary involvement, in contrast to Wegener’s 
granulomatosis and microscopic polyangiitis which presents with glomerulonephritis and 
frequent pulmonary manifestations (Frankel et al., 2002; Colmegna & Maldonado-Cocco, 
2005).  
Cutaneous manifestations occur in 20-50% of patients with classic PAN and include 
palpable purpura, while this is a manifestation of small vessel vasculitis, it does not exclude 
the diagnosis of PAN (Fiorentino, 2003). Other cutaneous findings indicative of medium 
sized vessel vasculitis include livedo reticularis, ulcers, and subcutaneous nodules 
(Fiorentino, 2003). Rare findings include ecchymosis, gangrene, and urticaria (Colmegna & 
Maldonado-Cocco, 2005).  
The classic histologic description of PAN requires the presence of a necrotizing vasculitis 
in medium sized vessels (see Figure 15) (Colmegna & Maldonado-Cocco, 2005). Four 
stages of histologic findings in PAN have been identified: degenerative, acute 
inflammatory, granulation tissue, and healed end-stage (Arkin, 1930). The degenerative 
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stage shows destructive coagulative necrosis of the media, fibrinous exudates 
surroundings the internal elastic lamina, neutrophilic infiltration, and partial destruction 
of the internal and external elastic lamina (Arkin, 1930). The acute inflammatory stage is 
characterized by infiltration of neutrophils, lymphocytes, and eosinophils, complete 
destruction of the internal elastic lamina, fibrinous exudates extending from the intima to 
the adventitia with complete destruction of the media, fibroblastic proliferation and 
edematous changes of the surrounding connective tissue, and total obliteration of the 
vessel lumen with fibrin thrombi (Arkin, 1930). In the granulation tissue stage, 
neutrophils are replaced by increasing numbers of lymphocytes, marked granulation 
tissue that replaces the media and extends into the adventitia and can invade through 
defects in the internal elastic lamina into the vessel lumen, and prolific intimal thickening 
(Arkin, 1930). The final stage, healed granulation tissue stage, is characterized by acellular 
scar tissue replacing the arterial wall and perivascular fibroblastic proliferation (Arkin, 
1930). 
 
 
 
 
Fig. 15. Polyarteritis Nodosa. Necrotizing vasculitis in a medium sized vessel (H&E, 100x). 
When an ulcerated lesion is present, a biopsy including adequate subcutis central to the 
ulcer border is essential to optimize the diagnostic yield (Ricotti et al., 2007). Biopsy of 
ulcerated lesions will demonstrate a vasculitis of medium sized vessels at the dermal 
subcutaneous junction with associated neutrophilic infiltration, leukocytoclasia, and 
endothelial swelling with overlying dermal fibrosis and necrosis and epidermal ulceration 
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(Ricotti et al., 2007). Lesions which present as subcutaneous nodules show a neutrophilic 
vasculitis of medium sized muscular vessels with a predilection for areas where arteries 
bifurcate (Carlson & Chen, 2007). 
3.1.1 Cutaneous polyarteritis nodosa 
Cutaneous polyarteritis nodosa (CPAN) is a limited form of PAN which presents with 
cutaneous findings, fever, myalgias, arthralgias, and peripheral neuropathy, but no other 
systemic symptoms (Fiorentino, 2003). It typically affects women more then men between 
the ages of 20 to 40 years (Chen & Carlson, 2008). Classic cutaneous manifestations include 
tender subcutaneous nodules which are usually limited to the lower extremities and 
buttocks (Carlson & Chen, 2007). Ulcerations with surrounding irregular livedo reticularis in 
a “burst” pattern are common in CPAN (Morgan & Schwartz, 2010). Other cutaneous 
findings include petechiae, purpura, necrosis, and gangrene (Morgan & Schwartz, 2010). 
Ulcerated lesions are more frequently found in patients with associated neuropathy and rare 
reports exist of these patients eventually progressing to classic PAN (Chen & Carlson, 2008). 
Patients with mononeuritis multiplex may also present with atrophie blanche without 
evidence of venous insufficiency and/or thrombophilia (Carlson & Chen, 2007). While 
patients with classic PAN can present with similar cutaneous findings, the lack of systemic 
multi-organ involvement in CPAN is an essential distinction between the two diseases 
(Morgan & Schwartz, 2010). 
The clinical severity of CPAN can be graded into three classes: class I or mild disease 
presents with subcutaneous nodules, livedo reticularis, and/or mild polyneuropathy; class 
II or severe disease presents with livedo, painful ulcerations, sensory neuropathy, fever, 
malaise, and arthralgia; and class III or progressive systemic disease presents with fever, 
malaise, arthralgia, deep ulcerations, necrotizing livedo, acral gangrene, foot drop 
mononeuropathy multiplex, worsening musculoskeletal symptoms, positive autoimmune 
serology, and eventual systemic involvement (Chen & Carlson, 2008). 
Similar to classic PAN, the etiology of CPAN is usually unknown although there is an 
association between CPAN and Group A β hemolytic Streptococcus, hepatitis B (although 
this association is not as well documented in CPAN as it is in classic PAN), hepatitis C, 
parvovirus B-19, tuberculosis, and minocycline (Morgan & Schwartz, 2010). 
The traditional description of CPAN on deep skin biopsy is a neutrophilic, necrotizing 
vasculitis of small to medium sized muscular arteries at the dermal-subcutaneous junction 
(Morgan & Schwartz, 2010). Similar to classic PAN, four stages of histologic findings in 
CPAN have been described;, however, the progression of arterial destruction is different in 
CPAN than classic PAN. The acute stage is characterized by a neutrophilic vasculitis of 
small to medium sized blood vessels and the dermal subcutaneous junction, damage to 
endothelial cells, fibrin thrombi within the vascular lumen, and no disruption of the internal 
elastic lamina (Ishibashi & Chen, 2008). The subacute stage shows focal disruption of the 
internal elastic lamina with fibrinoid necrosis of the media adjacent to the disruption, a 
targetoid appearance of vessels caused by subendothelial fibrinoid necrosis lined by an 
inner layer of intact endothelial cells and surrounded by the internal elastic lamina, and 
infiltration of the vessel wall by neutrophils, lymphocytes, and histiocytes (Ishibashi & 
Chen, 2008). The reparative stage shows a shift in the inflammatory cells to mostly 
lymphocytes and histiocytes, complete occlusion of the vascular lumen by fibrin thrombi, 
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and fibroblastic proliferation (Morgan & Schwartz, 2010). The healed stage shows 
discernible thickening of the intima with a scant inflammatory infiltrate surrounding the 
artery and perivascular neovascularization (Ishibashi & Chen, 2008). Direct 
immunofluorescence frequently reveals IgM and C3 deposition in and around deep dermal 
vessels, however, interestingly, IgG and IgA are almost universally negative in all cases of 
CPAN (Diaz-Perez et al., 1980). Since the histologic features diagnostic of CPAN, including 
neutrophilic vasculitis of medium sized vessels and the dermal subcutaneous junction, are 
segmental and focal, repeated and deeper biopsies followed by serial sectioning may be 
required for diagnosis (Chen & Carlson, 2008). 
The main diagnostic challenge for clinicians and dermatopathologists is the distinction 
between CPAN and thrombophlebitis. Thrombophlebitis is a vasculitis involving veins 
and venules while CPAN affects arteries (Chen, 2010). The distinction between veins and 
arteries is an important one in differentiating these two conditions. Features that 
histologically define an artery include a round vessel with a concentric, continuous 
wreath of smooth muscle fibers and a band of wavy elastic fibers between the intimal and 
medial layers of the vessel wall known as the internal elastic lamina while features of a 
vein include oval vessels with collagen admixed with smooth muscle and elastic fibers, 
but lacks an internal elastic lamina (Carlson, 2010). The presence or absence of an internal 
elastic lamina has long been cited by pathology textbooks as the distinction between 
arteries and veins, however, this distinction is blurred by increased hydrostatic pressure 
in the lower extremities which causes hypertrophy of the muscular layer and proliferation 
of elastic fibers in veins which can resemble the muscular layer and internal elastic lamina 
of arteries (Dalton et al., 2006). In fact, up to 44% of veins demonstrate an internal elastic 
lamina-like layer (Dalton et al., 2006). Three possible solutions have been suggested to 
avoid this diagnostic pitfall. The muscular pattern in arteries demonstrates a continuous 
wreath of smooth muscle while veins show bundles of smooth muscle admixed with 
collagen (Dalton et al., 2006). Next, the internal elastic lamina of an artery has an even 
thickness while the internal elastic lamina-like layer seen in veins is thinner and uneven in 
thickness (Chen, 2010). It is important to note, however, that the internal elastic lamina 
seen in arteries can lose its regular wavy appearance and thickness during the healing 
stages of arteritis (Ishiguro & Kawashima, 2010). Perhaps the most helpful tool in the 
histological distinction of a vein and artery is the use of an elastic stain which will 
demonstrate numerous elastic fibers in the muscular layers of a vein, but only scant fibers 
in the muscular layers of an artery (Chen, 2010).  
3.2 Kawasaki disease (also known as mucocutaneous lymph node syndrome) 
Kawasaki disease typically occurs in children less than four years of age and is defined 
clinically as a fever of 1-2 weeks duration which is unresponsive to antibiotics in conjunction 
with a constellation of symptoms including non-exudative conjunctivitis, oral 
manifestations (dry lips, strawberry tongue, etc.), erythematous and edematous palms and 
soles, polymorphous rash, and cervical lymphadenopathy (Hirose & Hamashima, 1978; 
Weston & Huff, 1981). Presence of at least five of the previously mentioned symptoms or 
four of the symptoms plus evidence of coronary artery aneurysm should be identified to 
diagnose Kawasaki disease (Kimura et al., 1988). The most feared complication of Kawasaki 
disease is a coronary artery aneurysm which develops in 20-25% of untreated patients and is 
the leading cause of acquired heart disease in children (Gedalia & Cuchacovich, 2009). 
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Cutaneous changes include edema and redness of the palms and soles which evolves into 
a macular eruption beginning on the extremities and spreading to the trunk (Kawasaki et 
al., 1974). The eruption then progresses into a morbilliform, scarlatiniform, or multiform 
eruption (Kawasaki et al., 1974). The morbilliform lesions consist of generalized macular 
and papular lesions which are clinically indistinguishable from a viral exanthem (Weston 
& Huff, 1981). The scarlantiniform eruption mimics the rash seen in scarlet fever or a drug 
eruption (Weston & Huff, 1981). The multiform lesions are typically targetoid lesions 
which do not progress to form blisters and can resemble erythema multiforme (Weston & 
Huff, 1981). Rarely patients can present with pustules superimposed on erythema 
(Kimura et al., 1988). Regardless of the initial presentation of the eruption, all patients 
advance to desquamation beginning in the periungual regions and progressing centrally 
to the trunk, a finding characteristic of but not unique to Kawasaki disease (Kawasaki et 
al., 1974). 
Skin biopsies reveal a superficial perivascular dermatitis characterized by dermal edema 
and mild perivascular lymphocytic inflammation (Weston & Huff, 1981). Papillary edema 
and minimal extravasation of red blood cells can be seen if the exanthem is biopsied within 
six days of onset (Hirose & Hamashima, 1978). Deposition of fibrinoid material and focal 
endothelial cell necrosis has been reported (Hirose & Hamashima, 1978). Vessel changes are 
most prominent in the medium sized vessel of the subcutis (Carlson & Chen, 2007). The 
pustular lesions show intraepidermal neutrophilic pustules, epidermal hyperplasia, 
superficial perivascular infiltrate with lymphocytes, neutrophils, and histiocytes, and 
neutrophilic inflammation around intraepidermal eccrine ducts (Kimura et al., 1988). Other 
diseases which present histologically with intraepidermal pustules such as pustular 
psoriasis, subcorneal pustular dermatosis, staphylococcal scalded skin syndrome, and milia 
should also be considered in the differential diagnosis (Kimura et al., 1988). Rare cases of 
psoriasiform-like hyperkeratosis have been reported (Passeron et al., 2002). 
3.3 Nodular vasculitis (also known as erythema induratum or erythema induratum of 
bazin) 
Nodular vasculitis (NV) is characterized by tender, indurated plaques on the calves of 
young to middle aged women and is associated with Mycobacterium tuberculosis (Schneider 
JW, 1997). The prodromal phase of NV occurs 1-3 weeks prior to the onset of lesions and 
consists of fever, malaise, arthritis, and arthralgias (Gilchrist & Patterson, 2010). NV presents 
as reoccurring crops of lesions lasting 2 weeks which heal with residual scarring and 
hyperpigmentation (Segura et al., 2008). 
Histologically, lobular panniculitis with necrotizing vasculitis that can be neutrophilic, 
lymphocytic, or granulomatous, is seen (see Figure 16) (Carlson & Chen, 2007). Early lesions 
show neutrophilic infiltration between fat lobules while established lesions show 
granulomatous infiltration of lobules (Segura et al., 2008). Two types of lesions can be seen. 
Type I is characterized by focal panniculitis and neutrophilic vasculitis of muscular vessels 
(Schneider & Jordaan, 1997). Type II lesions are characterized by diffuse septolobular 
panniculitis with numerous foci of neutrophilic small and medium sized vessel vasculitis 
(Schneider & Jordaan, 1997). Neutrophilic septal venulitis and arteritis is also common 
(Segura et al., 2008). Caseous necrosis can also be seen extending to the epidermal surface 
(Segura et al., 2008).  
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Fig. 16. Nodular Vasculitis. Suppurative necrosis of the subcutaneous fat surrounds this 
deep, inflamed vessel (H&E, 100x).  
4. Large vessel vasculitis 
4.1 Takayasu arteritis 
Takayasu arteritis (TA) is a large vessel granulomatous arteritis which typically involves the 
aorta and its main branches (Carlson & Chen, 2007). Patients are more commonly female in 
their second to third decade of life (Gedalia & Cuchacovich, 2009). The initial symptoms are 
nonspecific and usually consist of fever, fatigue, myalgias, arthralgias, and weight loss 
(Frankel et al., 2002). The most common clinical presentation is arterial hypertension, 
however, patients can also present with cardiac failure, bruits, and pulselessness (Gedalia & 
Cuchacovich, 2009). Other symptoms resulting from vessel occlusion and ischemia include 
claudication, syncope, headache, and visual disturbances (Frankel et al., 2002). Stenosis or 
aneurysm of the aorta or its major branches seen on angiography is the gold standard for the 
diagnosis of TA (Gedalia & Cuchacovich, 2009).  
Cutaneous involvement is rare in TA, occurring in 8-28% of patients (Carlson & Chen, 2007). 
Clinical findings include erythematous nodules, pyoderma gangrenosum-like ulcer, 
erythema nodosum, erythema induratum, and purpura (Perniciaro et al., 1987).  
During the acute phase of TA, the characteristic findings of granulomatous arteritis with 
transmural inflammation can be seen in the aorta or its branches (Lie, 1990). The 
morphologic findings on skin biopsy are generally non-specific and include granulomatous 
vasculitis, necrotizing vasculitis of the deep dermal medium sized vessels, and septal and 
lobular panniculitis with or without vasculitis (Pascual-Lόpez et al., 2004).  
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4.2 Giant cell arteritis (also known as temporal arteritis) 
Giant cell arteritis (GCA) is a granulomatous vasculitis of large arteries, particularly 
affecting the branches of the external carotid artery (Tsianakas et al., 2009). The prevalence is 
higher in women, the elderly, Caucasians, and patients with polymyalgia rheumatica (Chen 
& Carlson, 2008). Clinical symptoms are usually due to ischemia secondary to endarteritis 
obliterans and include headache, jaw cladication, and visual and neurological problems 
(Carlson & Chen, 2007). Timely diagnosis is imperative since significant morbidity, 
including visual loss, and even death may occur if treatment is delayed (Goldberg et al., 
1987). 
Cutaneous findings in GCA are rare, presenting in less than 1% of cases, and include scalp 
tenderness, loss or decrease in temporal pulse, scalp necrosis, and scalp blanching (Chen & 
Carlson, 2008). Erythema, ecchymoses, purpura, ulceration, gangrene, urticaria, erythema 
nodosum, and hyperpigmentation on the lower extremities have also been reported 
(Goldberg et al., 1987). Scalp necrosis is associated with increased risk of vision loss and 
carries a higher mortality rate (Tsianakas et al., 2009).  
The diagnostic features of GCA on temporal artery biopsy are segmental inflammation of 
the artery and infiltration of the media, adventitia, and internal elastic lamina by 
lymphocytes, neutrophils, and multinucleated giant cells (see Figures 17 and 18) 
(Goldberg et al., 1987). The segmental arterial involvement makes histologic diagnosis a 
challenge.  
 
 
Fig. 17. Giant Cell (Temporal) Arteritis. A dense granulomatous infiltrate effaces the elastic 
artery. The intima and media are particularly affected and giant cells may be conspicuous 
(H&E, 40x).  
www.intechopen.com
 Pathology of the Cutaneous Vasculitides: A Comprehensive Review 
 
145 
Lack of histologic evidence of GCA on temporal artery biopsy should not delay treatment in 
a patient clinically suspected of having GCA (Lie, 1990). Elastophagocytosis is a common 
finding (Carlson & Chen, 2007). Granulomatous infiltration of medium sized muscular 
vessels in the deep dermis or subcutaneous tissue is typically seen on skin biopsy (Chen & 
Carlson, 2008). Healing lesions are characterized by segmental stenosis and loss of the elastic 
lamina as well as myxomatous stromal replacement of the vessel wall (Carlson & Chen, 
2007). The lack of inflammation seen in completely healed lesions makes the distinction 
between GCA and atherosclerosis impossible (Carlson & Chen, 2007). 
 
 
Fig. 18. Giant cell arteritis. Staining for elastin fibers demonstrates fragmentation of the 
internal elastic lamina (elastic von Giesen stain, 200x). 
5. Conclusion 
Vasculitis is a broad, poorly defined category of diseases. The clinical presentation, 
progression of disease, and treatment vary as widely as the diseases themselves. Often times 
it is the compilation of clinical, laboratory, and pathologic findings which aid in formulating 
the diagnosis. 
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